Cameco (CCJ) slides 6.9% as uranium prices cool and sentiment turns risk-off

Cameco Corporation (CCJ) is down 6.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks most consistent with a pullback in uranium-linked equities as uranium pricing momentum cooled from recent highs, pressuring sentiment across the group. The decline may also reflect investors reacting to a recent analyst price-target cut that highlighted a tougher macro backdrop for commodities.

Details:

Industry pricing indicators showed uranium spot pricing falling in February versus January’s levels, even while remaining elevated versus mid-2024, which can weigh on near-term uranium equity momentum.

Uranium futures were described as trading in a relatively narrow range after pulling back from late-January highs, alongside broader industrial-commodity risk-off dynamics.

A large bank recently reduced its price target on Cameco while keeping a positive rating, framing the environment as more challenging for North American metals and mining coverage (a type of note that can trigger short-term de-risking).

This could also be a valuation-driven move, with traders taking profits after strong prior performance in the uranium complex.

Sources:

American Nuclear Society (Nuclear Newswire), TipRanks (TheFly), SEC (Form 6-K)

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CCJ Hedge Fund Activity

We have seen 487 institutional investors add shares of $CCJ stock to their portfolio, and 465 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 2,212,569 shares (-12.8%) from their portfolio in Q4 2025, for an estimated $202,427,937
FIL LTD removed 2,094,018 shares (-19.4%) from their portfolio in Q4 2025, for an estimated $191,581,706
CITIGROUP INC removed 1,781,746 shares (-71.4%) from their portfolio in Q4 2025, for an estimated $163,011,941
MARSHALL WACE, LLP added 1,729,454 shares (+7481.3%) to their portfolio in Q4 2025, for an estimated $158,227,746
RAILWAY PENSION INVESTMENTS LTD removed 1,653,600 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $138,670,896
ALLIANCEBERNSTEIN L.P. removed 1,638,428 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $149,899,777
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 1,556,157 shares (+12.0%) to their portfolio in Q4 2025, for an estimated $142,372,803

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CCJ Congressional Stock Trading

Members of Congress have traded $CCJ stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CCJ stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/17 and 2 sales worth up to $30,000 on 01/09, 12/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CCJ Analyst Ratings

Wall Street analysts have issued reports on $CCJ in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

GLJ Research issued a "Buy" rating on 02/18/2026
RBC Capital issued a "Outperform" rating on 11/13/2025
Goldman Sachs issued a "Buy" rating on 10/29/2025

To track analyst ratings and price targets for $CCJ, check out Quiver Quantitative's $CCJ forecast page.

$CCJ Price Targets

Multiple analysts have issued price targets for $CCJ recently. We have seen 4 analysts offer price targets for $CCJ in the last 6 months, with a median target of $150.0.

Here are some recent targets:

Gordon L. Johnson from GLJ Research set a target price of $171.2 on 02/18/2026
Andrew D. Wong from RBC Capital set a target price of $160.0 on 02/17/2026
George Eadie from UBS set a target price of $140.0 on 11/10/2025
Brian Lee from Goldman Sachs set a target price of $109.0 on 10/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.